AAD 2026Abstract 75559
Efficacy and safety of deucravacitinib vs placebo in patients with active psoriatic arthritis by concomitant methotrexate use
a pooled analysis of pivotal phase 3 studies
Merola JF, Gossec L, Armstrong AW, Pérez-Chada L, Thaçi D, Scher JU, Paul C, Plewinski M, Suryawanshi B, Varga S, Mease PJ
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: PsoriasisJAK inhibitors & other targeted pillsConventional systemic
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.739 · Not in PubMed: details from Crossref